Biontech Se

We track 2 ClinicalTrials.gov studies led by Biontech Se. The portfolio skews toward Phase 2 (2 trials).

2 clinical trials sponsored by Biontech Se.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials by Biontech Se

A Phase I/II, First-in-human, Open-label, Dose Escalation and Indication Expansion Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors

NCT07147348 · RECRUITING · Phase 2

A Phase I/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT323 in Combination With BNT327 in Participants With Advanced Breast Cancer

NCT06827236 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Biontech Se sponsor?

Biontech Se currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does Biontech Se research?

Biontech Se conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Biontech Se recruiting for clinical trials?

Yes, Biontech Se currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More